International Forum on Immunology and Clinical Immunotherapy
(IFICI-26)

14th November 2026 || Trivandrum - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Forum on Immunology and Clinical Immunotherapy (IFICI), scheduled to be held on 14th November 2026 in Trivandrum, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Immunology.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Cancer Immunotherapy
    This track will explore the latest breakthroughs in cancer immunotherapy, focusing on novel therapeutic strategies and their clinical applications. Discussions will include immune checkpoint inhibitors, therapeutic vaccines, and the integration of immunotherapy into standard cancer care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Autoimmune Disease Therapies
    This session will delve into innovative approaches for managing autoimmune diseases through immunotherapeutic interventions. Emphasis will be placed on emerging therapies and their mechanisms of action in modulating immune responses. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 03 – Monoclonal Antibodies in Clinical Practice
    This track will highlight the role of monoclonal antibodies in the treatment of various diseases, including cancer and autoimmune disorders. Participants will examine the development, efficacy, and safety profiles of these targeted therapies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Adoptive Cell Transfer Techniques
    This session will focus on the methodologies and clinical outcomes associated with adoptive cell transfer therapies, particularly in oncology. The discussion will include T cell engineering, tumor-infiltrating lymphocytes, and CAR T cell therapy. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 05 – Cytokine Therapy: Mechanisms and Applications
    This track will investigate the role of cytokines in immune modulation and their therapeutic potential in various diseases. Participants will discuss the latest research on cytokine therapies and their implications for clinical practice. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 06 – Immune Regulation and Tolerance
    This session will explore the mechanisms underlying immune regulation and tolerance, with a focus on their implications for therapy. Topics will include the role of regulatory T cells and the development of tolerance-inducing therapies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 07 – Clinical Trials in Immunotherapy
    This track will provide insights into the design and execution of clinical trials focused on immunotherapeutic agents. Participants will discuss challenges, regulatory considerations, and strategies for successful trial outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 08 – Translational Medicine in Immunology
    This session will highlight the translation of basic immunological research into clinical applications. Emphasis will be placed on bridging the gap between laboratory findings and patient care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 09 – Immune Biomarkers in Disease Management
    This track will examine the role of immune biomarkers in diagnosing and monitoring disease progression and treatment response. Discussions will include the identification and validation of biomarkers in clinical settings. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Cellular and Humoral Immunity: Interplay and Implications
    This session will explore the interactions between cellular and humoral immunity and their significance in health and disease. Participants will discuss how these immune responses can be harnessed for therapeutic purposes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 11 – Immune System Disorders: Pathogenesis and Therapy
    This track will focus on the pathophysiology of various immune system disorders and the therapeutic strategies employed to manage them. Emphasis will be placed on novel treatment modalities and their clinical implications. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure
  • SDG 10 SDG 10
    Reduced Inequalities

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228